Skip to main content

2 Result(s)

within D. Ribom Remove this filter English Remove this filter Oncology Remove this filter

and

  1. Article

    Open Access

    PROX1 is a predictor of survival for gliomas WHO grade II

    The clinical course of World Health Organisation grade II gliomas remains variable and their time point of transformation into a more malignant phenotype is unpredictable. Identification of biological markers ...

    T Elsir, M Qu, S G Berntsson, A Orrego, T Olofsson… in British Journal of Cancer (2011)

    Download PDF (1147 KB) View Article

  2. No Access

    Article

    Adding 11C-methionine PET to the EORTC prognostic factors in grade 2 gliomas

    The management of adult patients with grade 2 gliomas remains a challenge for the clinical neuro-oncologist. Several clinical prognostic factors appear to be as important as treatment factors in determining ou...

    A. Smits, E. Westerberg, D. Ribom in European Journal of Nuclear Medicine and M… (2008)